All News #Library
Biotech
Clene Highlights Stockholder Letter On Cnm-Au8 2026 Catalysts
24 Feb 2026 //
GLOBENEWSWIRE
Clene To Present At The Emerging Growth Conference
19 Feb 2026 //
GLOBENEWSWIRE
Clene To Present At The Emerging Growth Conference
16 Jan 2026 //
GLOBENEWSWIRE
Clene Reveals Cnm-Au8 Biomarker Data Backing NDA For FDA Meeting
12 Jan 2026 //
GLOBENEWSWIRE
Clene To Provide CNM-Au8® ALS Program Update
02 Dec 2025 //
GLOBENEWSWIRE
Clene To Attend Benchmark Investor Conference
20 Nov 2025 //
GLOBENEWSWIRE
Clene To Participate in Panel At Maxim Growth Summit
15 Oct 2025 //
GLOBENEWSWIRE
Clene Reports Q2 2025 Financials and Operational Highlights
14 Aug 2025 //
GLOBENEWSWIRE
Clene to Speak at Emerging Growth Conference
13 Aug 2025 //
GLOBENEWSWIRE
Clene to Present at the Emerging Growth Conference
12 Jul 2024 //
GLOBENEWSWIRE
Clene to Present at the Emerging Growth Conference
05 Jun 2024 //
GLOBENEWSWIRE
Clene to Present at Upcoming May Conferences
14 May 2024 //
GLOBENEWSWIRE
Clene Provides Update on ALS Clinical Development Meeting With FDA
21 Dec 2023 //
GLOBENEWSWIRE
Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels
21 Dec 2023 //
GLOBENEWSWIRE
Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference
25 Sep 2023 //
GLOBENEWSWIRE
Clene to Present at the Canaccord Genuity 43rd Annual Growth Conference
02 Aug 2023 //
GLOBENEWSWIRE
Clene to Participate in the Maxim Group Virtual Healthcare Conference
15 Jun 2023 //
GLOBENEWSWIRE
Clene Announces Launch of Proposed Public Offering
15 Jun 2023 //
GLOBENEWSWIRE
Clene Awarded Grant From National Multiple Sclerosis Society
25 May 2023 //
GLOBENEWSWIRE
Clene Nanomedicine to Participate in Roth 35th Annual Healthcare Conference
07 Mar 2023 //
GLOBENEWSWIRE
Clene Announces Participation in Renmark Virtual Non-Deal Roadshow Series
11 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support